期刊文献+

子宫内膜样腺癌中MDM2、Livin和Caspase-3蛋白及mRNA的表达 被引量:4

Expressions of MDM2,Livin and Caspase-3 protein and mRNA in endometrial adenocarcinomas
下载PDF
导出
摘要 目的探讨鼠双微体基因(MDM2)、凋亡蛋白抑制因子(Livin)、半胱氨酸天冬氨酸特异性蛋白酶3(Caspase-3)蛋白及mRNA在正常子宫内膜、子宫内膜增殖症和子宫内膜样腺癌(EA)中的表达及临床病理学意义。方法采用组织芯片技术结合免疫组化SP法及原位分子杂交方法,检测30例正常子宫内膜、30例单纯性增生、30例复杂伴不典型性增生、72例EA组织中MDM2、Livin、Caspase-3蛋白及mRNA的表达。结果 MDM2、Livin、Caspase-3蛋白及mRNA在EA中的表达率分别为80.6%(58/72)、80.6%(58/72)、33.3%(24/72)及73.6%(53/72)、75.0%(54/72)、27.8%(20/72),MDM2和L ivin表达率明显高于正常增生内膜(P<0.01),而Caspase-3阳性率明显低于正常增生内膜(P<0.01)。MDM2蛋白及mRNA过表达与组织分化、临床分期、浸润深度和淋巴结转移均无相关性;Livin和Caspase-3蛋白及mRNA阳性表达与组织分化有关(P<0.01或P<0.05),与临床分期、浸润深度及淋巴结转移均无相关性。MDM2、Livin、Caspase-3蛋白与相应的mRNA呈正相关;Livin与Caspase-3表达在蛋白及mRNA水平均呈负相关。结论 MDM2、Livin和Caspase-3蛋白及mRNA异常表达与EA的发生发展相关,有望成为EA早期诊断和预后判断的有价值标记物。 Objective To investigate the relationship of the expression of MDM2,Livin and Caspase-3 protein and mRNA in the development of endometrioid adenocarcinoma(EA).Methods The expression levels of MDM2,Livin and Caspase-3 proteins and mRNA in EA tissues(n=72),endometrial hyperplasia tissues(n=60) and normal tissues(n=30) were examined by tissue microarray technique,immunohistochemistry(SP method)and in situ hybridization method.Results The positive expression rates of MDM2,Livin and Caspase-3 protein and mRNA in EA were respectively 80.6%(58/72),80.6%(58/72),33.3%(24/72) and 73.6%(53/72),75.0%(54/72),27.8%(20/72).The positive rates of both MDM2 and Livin protein and mRNA in EA were higher than that in normal endometrium and endometrial hyperplasia(P0.01).However,the positive rate of Caspase-3 in EA was lower than that in normal endometrium and endometrial hyperplasia(P0.01).The positive expressions of MDM2 protein and mRNA were not related to the histological grade,FIGO stage,depth of invasion and lymph node metastasis.The positive expressions of Livin and Caspase-3 protein and mRNA were related to histological grade(P0.01,P0.05),but they were not related to FIGO stage,depth of invasion and the lymph node metastasis.The expressions of MDM2,Livin and Caspase-3 protein were positively correlated with their mRNA.The expression of Livin was negatively correlated Caspase-3.Conclusion The expressions of MDM2,Livin and Caspase-3 protein and mRNA correlate with the dedvelopment and progression of EA,which may be valuable biomarkers to detect the early carcinogenesis and prognosis of EA.
出处 《安徽医科大学学报》 CAS 北大核心 2011年第3期223-227,共5页 Acta Universitatis Medicinalis Anhui
基金 安徽省卫生厅医学科研项目(编号:2010B010)
关键词 子宫内膜肿瘤 半胱氨酸天冬氨酸蛋白酶3 endometrial neoplasms Caspase-3
  • 相关文献

参考文献4

二级参考文献38

  • 1吴玉新,王靖华,王华,杨新云.Ki-67、早期凋亡相关蛋白M30在子宫内膜癌的表达及其与预后的关系[J].中华病理学杂志,2003,32(4):314-318. 被引量:14
  • 2胡雪君,金波,马艳菊,温华,康健,刘云鹏.Rb2/p130基因编码蛋白在非小细胞肺癌中的表达及临床意义[J].中国医科大学学报,2006,35(6):631-633. 被引量:9
  • 3KASOF GM,GOMES BC. Livin: a novel inhibitor of apoptosis protein family member [ J ]. J Biol Chem, 2001,276( 5 ) : 3238.
  • 4LIN JH,DENG G,HUANG Q,et al. KIAP,a novel member of the inhibitor of apoptosis protein family [ J ]. Biochem Biophys Res Commun, 2000,279(3):820-831.
  • 5VUCIC D,STENNICKE HR,PISABARRO MT,et al. MT-1AP,a novel inhibitor of apoptosis that is preterentially expressed in human melanomas [J]. Curr Biol,2000,10(21) : 1359-1366.
  • 6ASHHAB Y ,ALIAN A,POLLIACK A,et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern [J]. FEBS Lett,2001,495(1-2) :56- 60.
  • 7BOAZ N,YUQOUB A,VERED B,et al. Caspase-mediated cleacage converts llvin from an antiapoptotic to a proapoptotlc factor: implications for drug-resistant melanoma [J]. Cancer Res,2003,63(10) :6340-6349.
  • 8KOUNELIS S, KAPRANOS N, KOURI E ,et al. Immunohistoehemical profile of endometrial adenocareinoma: a study of 61 cases and review of the literature [J]. Mod Pathol,2000,13(4) :379-388.
  • 9ABE H, SHIBATA MA, OTSUKI Y. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells [J]. Mol Hum Reprod,2006,12(9):535-541.
  • 10Andrilli G, MasciulloV, Bagella L, et al. Frequent loss of Rb2/ p130 in human ovarian carcinoma[ J ]. Clin Cancer Res,2004,10 (9) :3098 -3103.

共引文献97

同被引文献50

  • 1李惠平,张延平.p53核输入功能在鼠双微体2调节的p53蛋白降解和泛素化中的作用[J].中华肿瘤杂志,2005,27(2):86-89. 被引量:8
  • 2葛秀君,刘志辉,李英勇.mdm2蛋白在子宫颈鳞癌中的表达及意义[J].广东医学,2007,28(3):404-405. 被引量:2
  • 3黄金凤,李炜霞,何志明,章锦芳.子宫内膜癌MDM_2和CD44v6联合检测的临床意义[J].黑龙江医学,2007,31(4):243-244. 被引量:6
  • 4Oliner JD, Kinzler KW, Meltzer PS, et al. Amplifieation of a gene eneoding a P53 assoeiated protein in human sareoma [J]. Nature, 1992, 358 (6381): 80-83.
  • 5Masunaga R, Kohno H, Dhar DK, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients [J]. Clin Cancer Res, 2000, 6 (7): 4046-4068.
  • 6Sehmitt CA, Fridman JS, Yang M, et al. Dissecting p53 tumor suppressor Functions in vivo [J]. Cancer Cell, 2002, 1 (3): 335 346.
  • 7Huan JS, Ho TJ, Chiang CP, et al. MDM2 exression in area quid chewtng-associated oral squamous cells reinomas in Taiwan [J]. JOralPatholMed, 2001, 30 (1): 53-58.
  • 8RayburnE, Zhang R, He J, et al. MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy [J]. Curr Cancer Drug Targets, 2005, 5 (1): 27-41.
  • 9Vilar J B, Leite K R, Chen Chen L, et al. Antimutagenicity pro-tection of ginkgo biloba extract ( Egb761) against mitomycin C andcyclophosphamide in mouse bone marrow [ J]. Genet Mol Res,2009,8(1) : 328 -33.
  • 10El Mesallamy H 0, Metwally N S,Soliman MS, et al. The che-mopreventive effect of ginkgo biloba and silybum marianum extractson hepatocarcinogenesis in rats [ J]. Cancer Cell Int, 2011, 1(1): 38.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部